[SLN] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Jun-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- 0.00%
YoY-
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 4 38 38 21 21 63 63 -84.11%
PBT -2,812 -2,798 -2,798 -1,703 -1,703 -1,379 -1,379 60.87%
Tax 0 0 0 0 0 0 0 -
NP -2,812 -2,798 -2,798 -1,703 -1,703 -1,379 -1,379 60.87%
Tax Rate - - - - - - - -
Total Cost 2,816 2,836 2,836 1,724 1,724 1,442 1,442 56.29%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -80,342.86 -7,363.16 -7,363.16 -8,307.32 -8,307.32 -2,188.89 -2,188.89 1006.88%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -0.17 -0.18 -0.18 -0.13 -0.13 -0.15 -0.15 8.71%
EPS Diluted -0.17 -0.18 -0.18 -0.13 -0.13 -0.15 -0.15 8.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.